Callum Meikle
Directeur/Bestuurslid bij Scottish Ballet
Profiel
Callum Meikle has worked as a Director at Scottish Ballet and as a Non-Executive Director at Pleco Therapeutics BV.
Actieve functies van Callum Meikle
| Bedrijven | Functie | Begin |
|---|---|---|
Scottish Ballet
 Scottish Ballet Movies/EntertainmentConsumer Services Scottish Ballet operates as a dance company. The company was founded by Peter Darrell and Elizabeth West in 1957 and is headquartered in Glasgow, the United Kingdom. | Directeur/Bestuurslid | - |
Pleco Therapeutics BV
 Pleco Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Pleco Therapeutics BV is a Dutch clinical stage specialty pharmaceutical company that aims to improve the effectiveness of existing chemotherapy through its novel plecoid™ therapies. The company is based in Nijmegen, Netherlands. These therapies have the potential to positively change the balance of protein expression within the cancer microenvironment, removing the burden of toxic metals within the cell. The CEO of the company is Ivo Timmermans. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Scottish Ballet
Scottish Ballet Movies/EntertainmentConsumer Services Scottish Ballet operates as a dance company. The company was founded by Peter Darrell and Elizabeth West in 1957 and is headquartered in Glasgow, the United Kingdom. | Consumer Services |
Pleco Therapeutics BV
Pleco Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Pleco Therapeutics BV is a Dutch clinical stage specialty pharmaceutical company that aims to improve the effectiveness of existing chemotherapy through its novel plecoid™ therapies. The company is based in Nijmegen, Netherlands. These therapies have the potential to positively change the balance of protein expression within the cancer microenvironment, removing the burden of toxic metals within the cell. The CEO of the company is Ivo Timmermans. | Commercial Services |